Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

87.12 -3.93 (-4.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,301,095
Open 91.05
Bid (Size) 87.00 (5)
Ask (Size) 90.00 (9)
Prev. Close 91.05
Today's Range 87.02 - 91.99
52wk Range 47.46 - 100.85
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
PYLARIFY success leads to maximum payment in first year 
From Lantheus Holdings, Inc.
Via GlobeNewswire
7 Stocks That Wall Street Analysts Are Loving in May
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love. 
Via InvestorPlace

Performance

YTD
+71.94%
+71.94%
1 Month
+4.50%
+4.50%
3 Month
+17.79%
+17.79%
6 Month
+43.64%
+43.64%
1 Year
+27.15%
+27.15%

More News

Read More
Lantheus Holdings's Return On Capital Employed Overview
Via Benzinga
Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Lantheus Holdings Earnings Perspective: Return On Capital Employed
Via Benzinga
Why Shares of Lantheus Holdings Rose This Week
Via The Motley Fool
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
Via Investor's Business Daily
Why Shares of Lantheus Holdings Are Up Thursday
Via The Motley Fool
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Lantheus Reports First Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via GlobeNewswire
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Two Key Executive Promotions
From Lantheus Holdings, Inc.
Via GlobeNewswire
Are These Medical Device Makers Getting Ready To Rally?
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4
Via Benzinga
Lantheus Shares Jump On Upbeat 2023 Guidance, Q4 Earnings Surpass Expectations
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For February 23, 2023
Via Benzinga
Meet A Cannabis Executive Who Knows How To Reinvent The Business: Gary Santo Of TILT Holdings
Via Benzinga
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.